These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 27065336)
1. Semaphorin 7a exerts pleiotropic effects to promote breast tumor progression. Black SA; Nelson AC; Gurule NJ; Futscher BW; Lyons TR Oncogene; 2016 Sep; 35(39):5170-8. PubMed ID: 27065336 [TBL] [Abstract][Full Text] [Related]
2. Suppression of tumor-derived Semaphorin 7A and genetic ablation of host-derived Semaphorin 7A impairs tumor progression in a murine model of advanced breast carcinoma. Garcia-Areas R; Libreros S; Simoes M; Castro-Silva C; Gazaniga N; Amat S; Jaczewska J; Keating P; Schilling K; Brito M; Wojcikiewicz EP; Iragavarpu-Charyulu V Int J Oncol; 2017 Nov; 51(5):1395-1404. PubMed ID: 29048670 [TBL] [Abstract][Full Text] [Related]
3. Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival. Tarullo SE; Hill RC; Hansen KC; Behbod F; Borges VF; Nelson AC; Lyons TR Oncogene; 2020 Mar; 39(13):2772-2785. PubMed ID: 32020054 [TBL] [Abstract][Full Text] [Related]
4. Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer. Elder AM; Tamburini BAJ; Crump LS; Black SA; Wessells VM; Schedin PJ; Borges VF; Lyons TR Cancer Res; 2018 Nov; 78(22):6473-6485. PubMed ID: 30254150 [TBL] [Abstract][Full Text] [Related]
5. Semaphorin-7A contributes to growth, migration and invasion of oral tongue squamous cell carcinoma through TGF-β-mediated EMT signaling pathway. Liu TJ; Guo JL; Wang HK; Xu X Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1035-1043. PubMed ID: 29509252 [TBL] [Abstract][Full Text] [Related]
7. Hormonal Regulation of Semaphorin 7a in ER Crump LS; Wyatt GL; Rutherford TR; Richer JK; Porter WW; Lyons TR Cancer Res; 2021 Jan; 81(1):187-198. PubMed ID: 33122307 [TBL] [Abstract][Full Text] [Related]
8. Gene expression of semaphorin-3A, semaphorin-7A, neuropilin-1, plexin-C1, and β1 integrin in treated-multiple sclerosis patients. Shapoori S; Mosayebi G; Ebrahimi Monfared M; Ghazavi A; Khansarinejad B; Farahani I; Ganji A Neurol Res; 2020 Sep; 42(9):783-788. PubMed ID: 32497464 [TBL] [Abstract][Full Text] [Related]
9. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190 [TBL] [Abstract][Full Text] [Related]
10. Semaphorin-plexin signalling genes associated with human breast tumourigenesis. Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246 [TBL] [Abstract][Full Text] [Related]
15. Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis. Xie J; Wang H Arthritis Res Ther; 2017 Jan; 19(1):10. PubMed ID: 28109308 [TBL] [Abstract][Full Text] [Related]
16. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression. Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951 [TBL] [Abstract][Full Text] [Related]
17. Semaphorin 7A is expressed on airway eosinophils and upregulated by IL-5 family cytokines. Esnault S; Kelly EA; Johansson MW; Liu LY; Han ST; Akhtar M; Sandbo N; Mosher DF; Denlinger LC; Mathur SK; Malter JS; Jarjour NN Clin Immunol; 2014 Jan; 150(1):90-100. PubMed ID: 24333536 [TBL] [Abstract][Full Text] [Related]